Debate Series - Estro-events.org
Debate Series - Estro-events.org
Debate Series - Estro-events.org
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
sCiEnTiFiC proGrAMME<br />
Saturday 12 May 2012<br />
SYMPOSIUM<br />
pET And Mr iMAGinG possibiliTiEs And piTFAlls whEn UsEd For rT<br />
lEaRning ObJECTivES:<br />
1. To become familiar with the use of MRI and PET for RT planning<br />
2. To learn about challenges of quantitative imaging<br />
3. To learn about new imaging developments relevant for RT planning<br />
CliniCal inTERdiSCiPlinaRy PhySiCS RadiObiOlOgy RTT yOung<br />
Page 170 PROgRammE & ExhibiTiOn guidE • ESTRO 31<br />
abS. numbER<br />
14:30 - 15:45 • Room 116<br />
ChaiR: K. Tanderup (Denmark)<br />
CO-ChaiR: P. Carrasco de Fez (Spain)<br />
14:30 > Impact of image reconstruction and quantitative analysis on<br />
PET for RT planning<br />
SPEaKER: D. Thorwarth (Germany) SP-0519<br />
14:55 > The use of MRI in RT planning: potential, pitfalls and solutions<br />
SPEaKER: R. Wirestam (Sweden) SP-0520<br />
15:20 > Dynamic and diffusion weighted MRI: how to use it for RT<br />
SPEaKER: E. Malinen (Norway) SP-0521<br />
SYMPOSIUM<br />
hETEroGEnEiTy in TrEATMEnT rEsponsE:<br />
ThE wAy To pErsonAlisEd TrEATMEnT<br />
lEaRning ObJECTivES:<br />
1. To understand targeted therapies in oncology<br />
2. To get an insight in potential biomarkers for response<br />
3. To understand tumor hypoxia and possible biomarkers for its radiosensitization<br />
14:30 - 15:45 • Room 120-121<br />
ChaiR: G. Lammering (The Netherlands)<br />
CO-ChaiR: J. Gomez-Millan Barrachina (Spain)<br />
14:30 > EGFR signaling as a basis for personalize medicine<br />
SPEaKER: M. Krause (Germany) SP-0522<br />
14:55 > The importance of RAS mutations for targeted therapy in colon cancer<br />
SPEaKER: K. Haustermans (Belgium) SP-0523<br />
Saturday 12 May 2012<br />
abS. numbER<br />
15:20 > Hypoxia signatures predict benefit from radiosensitizers<br />
SPEaKER: J. Alsner (Denmark) SP-0524<br />
SYMPOSIUM<br />
rAdiobioloGy prinCiplEs: dosE ModiFiErs<br />
lEaRning ObJECTivES:<br />
1. To become familiar with how dose modifiers work, the therapeutic gain in RT as<br />
well as the limitations and the implications for the clinic<br />
2. To understand the effect of the time interval between RT and drugs with regards<br />
to the effect on tumor control and normal tissue damage and the pharmacological<br />
considerations<br />
3. To appreciate the benefit of radioprotectors with regards to biological mechanisms<br />
and the efficacy with regard to reduction of side effects as well as the potential risks<br />
14:30 - 15:45 • Room 118-119<br />
ChaiR: G. McColl (The Netherlands)<br />
CO-ChaiR: M.A. Gambacorta (Italy)<br />
14:30 > Is there a need for interval between drug and radiotherapy delivery?<br />
SPEaKER: F. Herrera (Switzerland) SP-0525<br />
14:55 > Opportunities of dose modifiers: illustrating the concepts<br />
and outlining the future<br />
SPEaKER: C. Vens (The Netherlands) SP-0526<br />
15:20 > Radioprotectors: general overview<br />
SPEaKER: H. Langendijk (The Netherlands) SP-0527<br />
POSTER DISCUSSION: 11<br />
prEdiCTiVE And snp<br />
14:45 - 15:30 • Poster Area<br />
ChaiR: J. Jaal (Estonia)<br />
CO-ChaiR: P. van Luijk (The Netherlands)<br />
> Germline MRE11 variants predictive of radiotherapy outcomes<br />
in bladder cancer by next-generation sequencing<br />
M.T.W. Teo (United Kingdom), H. Snowden, J. Nsengimana, M. Harland,<br />
J. M<strong>org</strong>an, I. Carr, G. Taylor, J. Barrett, D.T. Bishop, A.E. Kiltie Pd-0528<br />
ESTRO 31 • PROgRammE & ExhibiTiOn guidE Page 171<br />
sCiEnTiFiC proGrAMME<br />
eSTRO 31
Change language